Key Developments: Shandong Xinhua Pharmaceutical (00719): Received the approval notice for the marketing application of benserazide hydrochloride as a chemical active pharmaceutical ingredient. Guofu Quantum (00290): Entered into a strategic cooperation memorandum of understanding with Meditech Bio, planning to jointly establish a quantum computing center in Hong Kong. Harbour BioMed-B (02142): The investigational new drug application for HBM7004 was approved by the US FDA for the treatment of advanced solid tumors. Fosun Pharma (02196): Venlafaxine hydrochloride extended-release tablets were approved for marketing. SF Intra-City (09699): Subsidiary Shenzhen Intra-City plans to contribute RMB 213 million to participate in establishing an equity investment fund. Kelun-Biotech (06990): The marketing application for a new indication of the core product TROP2 ADC, sacituzumab govitecan (sac-TMT), was accepted by the National Medical Products Administration. Zhonghui Bio-B (02627): The Center for Drug Evaluation of China approved the IND application for the mRNA RSV vaccine. Mabwell Bio-B (02493): The clinical trial application for 9MW5211 injection was granted permission by the FDA. China Isotope & Radiation (01763): Subsidiary CNNC High-Tech and China Zhongyuan, together with Bond Bor, signed the "Technical Service Contract for the Thailand Secondary Standardized Neutron Dosimetry Laboratory Project." MicroPort CardioFlow-B (02160): The ENO™ series pacemaker received CE approval for the LBBAP indication. Hansoh Pharma (03692): The B7-H3-targeting antibody-drug conjugate HS-20093 for esophageal squamous cell carcinoma was included in the Breakthrough Therapy designation. CStone Pharma-B (02616): Initiated nationwide commercial shipment of domestically produced pralsetinib capsules. Yidu Tech (02158): Won the bid for the Smart Clinical and Settlement Service Upgrade Construction Project of Sun Yat-sen University Cancer Center affiliated with Bank of China Guangdong Branch. Minth Group (00425): Subsidiary signed a framework agreement with Allied-Lucky to establish a joint venture for jointly exploring the smart robot and robotic dog market.

Operating Performance: Greenland Hong Kong (00337): Contracted sales for the first four months amounted to approximately RMB 2.564 billion, representing a year-on-year increase of 191.36%. Weigao Group (01066): First-quarter revenue was approximately RMB 3.35 billion, a year-on-year increase of about 5.3%. FIH Mobile (02038): First-quarter profit was USD 3.069 million, a year-on-year increase of 186.29%. China Overseas Grand Oceans (00081): Cumulative contracted sales for the first four months reached RMB 11.432 billion, a year-on-year increase of 19.6%. China Overseas Land & Investment (00688): Cumulative contracted property sales for the first four months amounted to approximately RMB 75.711 billion, a year-on-year increase of 13.7%. Q Technology (01478): Sales of mobile phone camera modules in April reached 41.898 million units, a month-on-month increase of 7.7% and a year-on-year increase of 31.8%. DAMAI ENT (01060): Issued a positive profit alert, expecting annual net profit attributable to shareholders to be no less than RMB 700 million. Tianrun Cloud (02167): Revenue from AI digital workforce solutions and AI-enhanced solutions in the first quarter increased by approximately 105% year-on-year.